Journal details
EXPERT OPINION ON DRUG DISCOVERY
TAYLOR & FRANCIS LTD · ISSN 1746-0441 · eISSN 1746-045X
SCIEScopusMEDLINEPubMedPMC
Overview
EXPERT OPINION ON DRUG DISCOVERY. ISSN 1746-0441 · eISSN 1746-045X. published by TAYLOR & FRANCIS LTD. England. Pharmacology & Pharmacy. impact factor 7.3 (2025). JCR Q1. CAS Zone 2. indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Figures below are the public fields already in this dataset. Confirm scope, APC and policies on the journal website before you submit.
Publication output
2026: 46 articles · 2025: 110 articles · 2024: 95 articles. Source: OpenAlex open data.
FAQ
What is the impact factor of EXPERT OPINION ON DRUG DISCOVERY?
The impact factor recorded for EXPERT OPINION ON DRUG DISCOVERY is 7.3 (2025 JCR release), JCR quartile Q1.
What is the CAS zone (Chinese Academy of Sciences ranking) of EXPERT OPINION ON DRUG DISCOVERY?
EXPERT OPINION ON DRUG DISCOVERY is listed in CAS Zone 2.
Which databases index EXPERT OPINION ON DRUG DISCOVERY?
EXPERT OPINION ON DRUG DISCOVERY is indexed in SCIE, Scopus, MEDLINE, PubMed, PMC. Confirm on the journal website and the database itself before submitting.